A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study

INTRODUCTION: The LumiraDx severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen test, which uses a high-sensitivity, microfluidic immunoassay to detect the nucleocapsid protein of SARS-CoV-2, was evaluated for diagnosing acute coronavirus disease 2019 (COVID-19) in adults and childre...

Descripción completa

Detalles Bibliográficos
Autores principales: Drain, Paul K., Ampajwala, Madhavi, Chappel, Christopher, Gvozden, Andre B., Hoppers, Melanie, Wang, Melody, Rosen, Robert, Young, Stephen, Zissman, Edward, Montano, Michalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904038/
https://www.ncbi.nlm.nih.gov/pubmed/33629225
http://dx.doi.org/10.1007/s40121-021-00413-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904038/
https://www.ncbi.nlm.nih.gov/pubmed/33629225
http://dx.doi.org/10.1007/s40121-021-00413-x

Ejemplares similares